Yoko Franchetti
Impact in
-
- Gastric Cancer Management and Outcomes
- Renal cell carcinoma treatment
-
- Esophageal Cancer Research and Treatment
- Esophageal and GI Pathology
Papers in
- Oncology 4
- Drug Transport and Resistance Mechanisms 3
-
- Pharmacogenetics and Drug Metabolism 3
- Antibiotics Pharmacokinetics and Efficacy 2
- Co-authors
- Thomas D. Nolin (4 shared papers)Toni K. Choueiri (2 shared papers)David J. Sugarbaker (1 shared paper)Al B. Benson (1 shared paper)Annick D. Van den Abbeele (2 shared papers)Hiran C. Fernando (1 shared paper)Mizuki Nishino (2 shared papers)Katherine M. Krajewski (2 shared papers)
- Journals
- The Journal of Clinical Pharmacology (4 papers)Clinical Breast Cancer (1 paper)Journal of Biopharmaceutical Statistics (1 paper)Clinical Journal of the American Society of Nephrology (1 paper)Annals of Surgery (1 paper)
- Partner nations
- United StatesJapan
In The Last Decade
Yoko Franchetti
12 papers receiving 342 citations
Peers
Comparison fields: 5 of 62
- Pulmonary and Respiratory Medicine 105
- Surgery 138
- Gastroenterology 10
- Nephrology 12
- Biological Psychiatry 4
Countries citing papers authored by Yoko Franchetti
This map shows the geographic impact of Yoko Franchetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Franchetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Franchetti more than expected).
Fields of papers citing papers by Yoko Franchetti
This network shows the impact of papers produced by Yoko Franchetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Franchetti. The network helps show where Yoko Franchetti may publish in the future.
Co-authors
The 25 scholars most cited alongside Yoko Franchetti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 147 | |
| 2 | 2019 | 56 | |
| 3 | 2013 | 43 | |
| 4 | 2014 | 38 | |
| 5 | 2020 | 19 | |
| 6 | 2021 | 12 | |
| 7 | 2014 | 11 | |
| 8 | 2021 | 7 | |
| 9 | 2013 | 6 | |
| 10 | 2018 | 3 | |
| 11 | 2019 | 2 | |
| 12 | Is SUVmax in baseline PET/CT scans of patients with inflammatory breast cancer (IBC) associated with a complete pathologic response in mastectomy tissue after neoadjuvant chemotherapy? | 2013 | 1 |
| 13 | 2021 | 0 |
About Yoko Franchetti
Yoko Franchetti is a scholar working on Oncology, Pharmacology, Pharmacology, Statistics and Probability and Surgery, having authored 13 papers that have together received 345 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Statistical Methods in Clinical Trials (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Allergic Rhinitis and Sensitization (1 paper), Renal cell carcinoma treatment (1 paper), MRI in cancer diagnosis (1 paper) and Advanced Causal Inference Techniques (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (105 citations), Surgery (138 citations), Gastroenterology (10 citations), Nephrology (12 citations) and Biological Psychiatry (4 citations). Yoko Franchetti has collaborated with scholars based in United States and Japan. Frequent co-authors include Thomas D. Nolin, Toni K. Choueiri, David J. Sugarbaker, Al B. Benson, Annick D. Van den Abbeele, Hiran C. Fernando, Mizuki Nishino, Katherine M. Krajewski, James D. Luketich and Michael A. Maddaus. Their work appears in journals such as The Journal of Clinical Pharmacology, Clinical Breast Cancer, Journal of Biopharmaceutical Statistics, Clinical Journal of the American Society of Nephrology and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.